| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 2006 | 2020 | ||||||||
|
amyloid beta precursor protein | 0.422 | 0.846 | 4.7E-02 |
|
disease | 0.330 | None | 0.800 | 5 | 0 | 1999 | 2018 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
disease | 0.350 | None | 1.000 | 5 | 0 | 2012 | 2019 | ||||||||
|
tryptophan hydroxylase 2 | 0.546 | 0.654 | 2.5E-07 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 2005 | 2019 | ||||||||
|
artemin | 0.480 | 0.846 | 0.36 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 2008 | 2019 | ||||||||
|
neuropeptide Y | 0.447 | 0.846 | 0.14 |
|
disease | 0.600 | None | 1.000 | 5 | 0 | 2002 | 2019 | ||||||||
|
ataxin 3 | 0.521 | 0.808 | 0.11 |
|
disease | 0.330 | None | 1.000 | 5 | 0 | 1993 | 2017 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 2007 | 2020 | ||||||||
|
period circadian regulator 2 | 0.488 | 0.846 | 0.71 |
|
disease | 0.350 | None | 1.000 | 5 | 0 | 2010 | 2018 | ||||||||
|
corticotropin releasing hormone receptor 1 | 0.517 | 0.769 | 3.8E-05 |
|
disease | 0.600 | None | 1.000 | 5 | 0 | 2004 | 2019 | ||||||||
|
nitric oxide synthase 2 | 0.364 | 0.923 | 4.0E-15 |
|
disease | 0.350 | None | 1.000 | 5 | 0 | 2009 | 2018 | ||||||||
|
monoamine oxidase A | 0.465 | 0.769 | 1.00 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 2001 | 2019 | ||||||||
|
nuclear receptor subfamily 3 group C member 2 | 0.469 | 0.846 | 0.84 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 2001 | 2019 | ||||||||
|
corticotropin releasing hormone | 0.439 | 0.808 | 0.72 |
|
disease | 0.600 | None | 1.000 | 5 | 0 | 1992 | 2019 | ||||||||
|
cAMP responsive element binding protein 1 | 0.463 | 0.885 | 1.00 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 2005 | 2019 | ||||||||
|
catechol-O-methyltransferase | 0.400 | 0.923 | 1.1E-06 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 1983 | 2019 | ||||||||
|
calmodulin 2 | 0.472 | 0.808 | 0.92 |
|
disease | 0.310 | None | 0.800 | 5 | 0 | 2005 | 2014 | ||||||||
|
cannabinoid receptor 2 | 0.509 | 0.846 | 6.5E-06 |
|
disease | 0.350 | None | 1.000 | 5 | 0 | 2006 | 2019 | ||||||||
|
cannabinoid receptor 1 | 0.446 | 0.808 | 0.51 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 2005 | 2019 | ||||||||
|
calcium voltage-gated channel subunit alpha1 C | 0.510 | 0.846 | 1.00 |
|
disease | 0.370 | None | 0.800 | 5 | 0 | 2010 | 2017 | ||||||||
|
potassium two pore domain channel subfamily K member 2 | 0.626 | 0.654 | 1.9E-02 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 2007 | 2019 | ||||||||
|
cytochrome P450 family 2 subfamily D member 6 | 0.437 | 0.885 | 1.1E-25 |
|
disease | 0.400 | None | 0.800 | 5 | 0 | 1996 | 2020 | ||||||||
|
TNF receptor superfamily member 1A | 0.409 | 0.923 | 0.99 |
|
disease | 0.360 | None | 0.800 | 5 | 0 | 2006 | 2019 | ||||||||
|
dopamine receptor D3 | 0.529 | 0.692 | 2.4E-03 |
|
disease | 0.370 | None | 1.000 | 5 | 0 | 2007 | 2019 | ||||||||
|
dopamine receptor D4 | 0.517 | 0.577 | 9.3E-09 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 1998 | 2018 |